These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5610312)

  • 1. [Experiences from medical practice with a combination of l-alpha-methyldopa and cyclazenin (Tadip)].
    Terhedebrügge A
    Med Welt; 1967 Dec; 48():2928-30. PubMed ID: 5610312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the blood pressure lowering effect of cyclazenin and a cyclazenin-alpha-methyldopa combination].
    Seige K; Preuss EG; Mörl H; Köhler I; Lantzsch W
    Med Welt; 1969 Mar; 10():520-6. PubMed ID: 5772239
    [No Abstract]   [Full Text] [Related]  

  • 3. [The broad-spectrum antihypertensive agent Tadip in slight and moderate hypertension].
    Kempf E
    Med Monatsschr; 1968 Jun; 22(6):270-5. PubMed ID: 5720912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hypertension with Leron (cyclacenin) and Tadip (cyclacenin and alpha-methyldopa)].
    Stampfer E
    Wien Med Wochenschr; 1968 Jun; 118(24):551-4. PubMed ID: 5711781
    [No Abstract]   [Full Text] [Related]  

  • 5. [Simplified treatment of hypertension using Tadip].
    Kumpmann U
    Med Welt; 1968 Nov; 46():2553-6. PubMed ID: 5731380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with a new antihypertensive agent (Tadip)].
    Becker L
    Med Welt; 1968 Jul; 30():1684-5. PubMed ID: 5718817
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of a new antihypertensive combination (cyclazenine + presinol)].
    Ambrosioni E
    G Clin Med; 1967 Nov; 48(11):1149-62. PubMed ID: 5617984
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic trials with the new antihypertensive agent Tadip].
    Stein G
    Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
    [No Abstract]   [Full Text] [Related]  

  • 9. The combined effect of propranolol with bethanidine or methyldopa in hypertension.
    Prichard BN
    Adv Clin Pharmacol; 1976; 11():107-13. PubMed ID: 1032568
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of guanoclor and methyldopa in the treatment of severe hypertension.
    Mackinnon J; el-Baz LM
    Br J Clin Pract; 1971 Mar; 25(3):135-7. PubMed ID: 4929159
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative human studies of a new anti-hypertensive drug (2,6-dichloro-benzylidene-aminoguanidine acetate) and methyldopa in hypertensive patients].
    Baldrighi V; Baldrighi G; Ronzoni L; Aiazzi L; Caprioli G
    Arch Sci Med (Torino); 1977; 134(2):185-92. PubMed ID: 869702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)].
    Vejlsgaard V; Christensen M; Clausen E
    Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-hypertensive effectiveness of guanfacine and methyldopa: comparison of groups of patients].
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Cardiologia; 1982; 27(4):357-63. PubMed ID: 6765262
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-hypertensive efficacy of guanfacine and methyldopa: intra-patient comparison].
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Cardiologia; 1982; 27(4):357-63. PubMed ID: 6765437
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The behavior of several serum lipoids during treatment of hypertension].
    Gross W
    Verh Dtsch Ges Inn Med; 1965; 71():441-5. PubMed ID: 5877654
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of essential arterial hypertension with a combination of clonidine and alpha-methyldopa].
    Melina D; Guerrera G
    Clin Ter; 1980 Mar; 92(6):635-48. PubMed ID: 7460492
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with a new hypotensive agent].
    Kühns K; Janocha U; Magnus D
    Hospital (Rio J); 1967 Oct; 72(4):1167-74. PubMed ID: 5306982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.